• JNJ

Wells Fargo says there is a risk that Johnson & Johnson will guide lower

Wells Fargo analysts warn Johnson & Johnson may lower 2024 earnings guidance due to acquisitions, while stable sales growth is expected despite potential challenges from litigation and business performance.

• JNJ

J&J to invest over $2 billion for new manufacturing facility in North Carolina

Johnson & Johnson plans to invest over $2 billion in a new manufacturing facility in North Carolina to enhance the production of biologic medications, targeting 70 new therapies by 2030.

• BIIB
• CRM
• CSCO
• JNJ
• TGT
• US500

Buy US stocks with less demanding valuations: HSBC

HSBC analysts suggest focusing on stocks with lower valuations as S&P 500 hits record highs, while advising against small cap investments due to historical underperformance.

• JNJ

J&J unit files for bankruptcy to advance $10 billion talc settlement

Johnson & Johnson's subsidiary filed for bankruptcy again, seeking a $10 billion cancer lawsuit settlement. The proposed deal is contested by some attorneys and faces legal challenges.

• JNJ

Johnson & Johnson adds $1.1 billion to proposed talc settlement

• JNJ

Judge rules J&J owes Auris investors $1 billion related to 2019 robotics deal

• AMGN
• AZN
• BMY
• JNJ
• MRK
• PFE

US will still pay at least twice as much after negotiating drug prices

The U.S. negotiated drug prices under Medicare remain significantly higher than those in other wealthy nations, highlighting disparities in healthcare costs and market dynamics.

• CEG
• GD
• JNJ
• MRK
• MSFT
• MTB
• SBUX
• TMUS

Morgan Stanley updated its Dividend Equity Portfolio, dropped this big tech name

Morgan Stanley refreshes its Dividend Equity Portfolio, dropping Microsoft and adding General Dynamics and Constellation Energy to enhance dividend yield and defensive characteristics.

• JNJ

Tylenol maker defeats lawsuit over labeling

Kenvue won a lawsuit claiming 'Rapid Release' Tylenol gelcaps provided faster pain relief, as federal law preempts consumers' New York state claims regarding labeling and efficacy.